{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:15:32Z","timestamp":1790612132755,"version":"4.1.0"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"Supplement_6","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1127988"],"award-info":[{"award-number":["OPP1127988"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1201031"],"award-info":[{"award-number":["OPP1201031"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,10,30]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The Typhoid Surveillance in Africa Program (TSAP) and the Severe Typhoid Fever in Africa (SETA) program have refined our understanding of age and geographic distribution of typhoid fever and other invasive salmonelloses in Africa and will help inform future typhoid control strategies, namely, introduction of typhoid conjugate vaccines.<\/jats:p>","DOI":"10.1093\/cid\/ciz637","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T23:24:46Z","timestamp":1568071486000},"page":"S413-S416","source":"Crossref","is-referenced-by-count":13,"title":["The Severe Typhoid Fever in Africa Program Highlights the Need for Broad Deployment of Typhoid Conjugate Vaccines"],"prefix":"10.1093","volume":"69","author":[{"given":"Megan E","family":"Carey","sequence":"first","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, Seattle, Washington"},{"name":"Department of Medicine, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Duncan","family":"Steele","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"key":"2019103013462519000_CIT0001","first-page":"346","article-title":"Global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"2019103013462519000_CIT0002","doi-asserted-by":"crossref","first-page":"4","DOI":"10.4269\/ajtmh.18-0032","article-title":"Introductory article on global burden and epidemiology of typhoid fever","volume":"99","author":"Radhakrishnan","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2019103013462519000_CIT0003","first-page":"49","article-title":"Typhoid vaccines: WHO position paper","volume":"83","author":"World Health Organization","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"key":"2019103013462519000_CIT0004","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/cid\/civ675","article-title":"What have we learned from the typhoid fever surveillance in Africa program?","volume":"62","author":"Baker","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2019103013462519000_CIT0005","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive Salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2019103013462519000_CIT0006","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1093\/cid\/civ787","article-title":"Variations of invasive Salmonella infections by population size in Asante Akim North Municipal, Ghana","volume":"62","author":"Cruz Espinoza","year":"2016","journal-title":"Clin Infect Dis"},{"key":"2019103013462519000_CIT0007","article-title":"Phase I of the Surveillance for Enteric Fever in Asia Project (SEAP): an overview and lessons learned","author":"Barkume","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2019103013462519000_CIT0008","doi-asserted-by":"crossref","first-page":"S268","DOI":"10.1093\/infdis\/jiy494","article-title":"Integrating facility-based surveillance with healthcare utilization surveys to estimate enteric fever incidence: methods and challenges","volume":"218","author":"Andrews","year":"2018","journal-title":"J Infect Dis"},{"key":"2019103013462519000_CIT0009","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3201\/eid0905.020428","article-title":"Estimating the incidence of typhoid fever and other febrile illnesses in developing countries","volume":"9","author":"Crump","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"2019103013462519000_CIT0010","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1016\/j.vaccine.2010.05.040","article-title":"A low-cost approach to measure the burden of vaccine preventable diseases in urban areas","volume":"28","author":"Luby","year":"2010","journal-title":"Vaccine"},{"key":"2019103013462519000_CIT0011","doi-asserted-by":"crossref","first-page":"C3","DOI":"10.1016\/j.vaccine.2015.02.054","article-title":"Towards sustainable public health surveillance for enteric fever","volume":"33","author":"Luby","year":"2015","journal-title":"Vaccine"},{"key":"2019103013462519000_CIT0012","doi-asserted-by":"crossref","first-page":"e016283","DOI":"10.1136\/bmjopen-2017-016283","article-title":"The STRATAA study protocol: a programme to assess the burden of enteric fever in Bangladesh, Malawi and Nepal using prospective population census, passive surveillance, serological studies and healthcare utilisation surveys","volume":"7","author":"Darton","year":"2017","journal-title":"BMJ Open"},{"key":"2019103013462519000_CIT0013","first-page":"153","article-title":"Typhoid vaccines: WHO position paper\u2014March 2018","volume":"13","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"2019103013462519000_CIT0014","volume-title":"New typhoid vaccine to receive Gavi support","author":"Gavi, the Vaccine Alliance","year":"2018"},{"key":"2019103013462519000_CIT0015","volume-title":"Typhoid vaccine prequalified","author":"World Health Organization","year":"2018"},{"key":"2019103013462519000_CIT0016","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1016\/j.vaccine.2017.08.001","article-title":"The Typhoid Vaccine Acceleration Consortium (TyVAC): vaccine effectiveness study designs: accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26-27 October 2016, Oxford, UK","volume":"35","author":"Meiring","year":"2017","journal-title":"Vaccine"},{"key":"2019103013462519000_CIT0017","unstructured":"Date K . Navi Mumbai Municipal Corporation launches the world\u2019s first public sector typhoid conjugate vaccine campaign. Take on Typhoid. 2018. Available at: http:\/\/www.coalitionagainsttyphoid.org\/navi-mumbai-municipal-corporation-launches-the-worlds-first-public-sector-typhoid-conjugate-vaccine-campaign\/. Accessed 15 March 2019."},{"key":"2019103013462519000_CIT0018","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1093\/cid\/ciy884","article-title":"Overview of the typhoid conjugate vaccine pipeline: current status and future plans","volume":"68","author":"Sahastrabuddhe","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2019103013462519000_CIT0019","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz715","article-title":"The Severe Typhoid in Africa program protocol: assessing the burden, severity, host immunity, and carriage associated with invasive salmonellosis using prospective sentinel-based passive surveillance, healthcare utilization surveys, and prospective case-controlled and cohort study designs","author":"Park","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2019103013462519000_CIT0020","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz608","article-title":"A multicenter cost of illness and long-term socioeconomic follow-up under the Severe Typhoid in Africa program: a study protocol","author":"Ramani","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2019103013462519000_CIT0021","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz525","article-title":"A systematic review of typhoid fever occurrence in Africa","author":"Kim","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2019103013462519000_CIT0022","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz705","article-title":"Spatial and temporal patterns of typhoid and paratyphoid fever outbreaks: a worldwide systematic review, 1990\u20132016","author":"Kim","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2019103013462519000_CIT0023","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz477","article-title":"Occurrence of typhoid fever complications and their relation to duration of illness preceding hospitalization: a systematic literature review and meta-analysis","volume-title":"Clin Infect Dis","author":"Espinoza","year":"2019"},{"key":"2019103013462519000_CIT0024","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz620","article-title":"Acute Febrile Illness Among Children in Butajira, South\u2013Central Ethiopia During the Typhoid Fever Surveillance in Africa Program","author":"Teferi","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2019103013462519000_CIT0025","article-title":"The epidemiology of dengue outbreaks in 2016 and 2017 in Ouagadougou, Burkina Faso","author":"Im","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2019103013462519000_CIT0026","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz516","article-title":"Bacteremia among febrile patients attending selected health facilities in Ibadan, Nigeria","author":"Popoola","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2019103013462519000_CIT0027","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz629","article-title":"How can the Typhoid Fever Surveillance in Africa (TSAP) and the Severe Typhoid in Africa (SETA) programs contribute to the introduction of typhoid conjugate vaccines?","author":"Jeon","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2019103013462519000_CIT0028","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz450","article-title":"Multicountry distribution and characterization of extended spectrum-lactamase (ESBL) associated bacteria from bloodstream infections in sub-Saharan Africa","author":"Toy","year":"2019","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/Supplement_6\/S413\/30328153\/ciz637.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/69\/Supplement_6\/S413\/30328153\/ciz637.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T17:20:59Z","timestamp":1575652859000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/69\/Supplement_6\/S413\/5609446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":28,"journal-issue":{"issue":"Supplement_6","published-online":{"date-parts":[[2019,10,30]]},"published-print":{"date-parts":[[2019,10,30]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciz637","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11,15]]},"published":{"date-parts":[[2019,10,30]]}}}